{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T21:21:59Z","timestamp":1792876919538,"version":"4.5.0"},"reference-count":51,"publisher":"American Medical Association (AMA)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2022.7970","type":"journal-article","created":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T15:18:46Z","timestamp":1650381526000},"page":"e227970","source":"Crossref","is-referenced-by-count":50,"title":["Identification of Drug Interaction Adverse Events in Patients With COVID-19"],"prefix":"10.1001","volume":"5","author":[{"given":"Valeria","family":"Conti","sequence":"first","affiliation":[{"name":"Department of Medicine, Surgery, and Dentistry, Scuola Medica Salernitana, University of Salerno, Baronissi, Italy"},{"name":"Clinical Pharmacology Unit, San Giovanni di Dio e Ruggi d\u2019Aragona University Hospital, Salerno, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmine","family":"Sellitto","sequence":"additional","affiliation":[{"name":"Department of Medicine, Surgery, and Dentistry, Scuola Medica Salernitana, University of Salerno, Baronissi, Italy"},{"name":"Doctoral School, Department of Medicine, Surgery and Dentistry \u201cScuola Medica Salernitana,\u201d University of Salerno, Baronissi, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Torsiello","sequence":"additional","affiliation":[{"name":"Department of Medicine, Surgery, and Dentistry, Scuola Medica Salernitana, University of Salerno, Baronissi, Italy"},{"name":"Clinical Pharmacology Unit, San Giovanni di Dio e Ruggi d\u2019Aragona University Hospital, Salerno, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Manzo","sequence":"additional","affiliation":[{"name":"Department of Medicine, Surgery, and Dentistry, Scuola Medica Salernitana, University of Salerno, Baronissi, Italy"},{"name":"Clinical Pharmacology Unit, San Giovanni di Dio e Ruggi d\u2019Aragona University Hospital, Salerno, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"De Bellis","sequence":"additional","affiliation":[{"name":"Clinical Pharmacology Unit, San Giovanni di Dio e Ruggi d\u2019Aragona University Hospital, Salerno, Italy"},{"name":"Postgraduate Department of Medicine, Surgery and Dentistry \u201cScuola Medica Salernitana,\u201d University of Salerno, Baronissi, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berenice","family":"Stefanelli","sequence":"additional","affiliation":[{"name":"Clinical Pharmacology Unit, San Giovanni di Dio e Ruggi d\u2019Aragona University Hospital, Salerno, Italy"},{"name":"Postgraduate Department of Medicine, Surgery and Dentistry \u201cScuola Medica Salernitana,\u201d University of Salerno, Baronissi, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Bertini","sequence":"additional","affiliation":[{"name":"Clinical Pharmacology Unit, San Giovanni di Dio e Ruggi d\u2019Aragona University Hospital, Salerno, Italy"},{"name":"Postgraduate Department of Medicine, Surgery and Dentistry \u201cScuola Medica Salernitana,\u201d University of Salerno, Baronissi, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Costantino","sequence":"additional","affiliation":[{"name":"Department of Medicine, Surgery, and Dentistry, Scuola Medica Salernitana, University of Salerno, Baronissi, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Maci","sequence":"additional","affiliation":[{"name":"Department of Medicine, Surgery, and Dentistry, Scuola Medica Salernitana, University of Salerno, Baronissi, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuel","family":"Raschi","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences, Alma Mater Studiorum, University of Bologna, Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Sabbatino","sequence":"additional","affiliation":[{"name":"Department of Medicine, Surgery, and Dentistry, Scuola Medica Salernitana, University of Salerno, Baronissi, Italy"},{"name":"Oncology Unit, San Giovanni di Dio e Ruggi d\u2019Aragona University Hospital, Salerno, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graziamaria","family":"Corbi","sequence":"additional","affiliation":[{"name":"Department of Medicine and Health Sciences, University of Molise, Campobasso, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasquale","family":"Pagliano","sequence":"additional","affiliation":[{"name":"Department of Medicine, Surgery, and Dentistry, Scuola Medica Salernitana, University of Salerno, Baronissi, Italy"},{"name":"Infectious Diseases Unit, San Giovanni di Dio e Ruggi d\u2019Aragona University Hospital, Salerno, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelia","family":"Filippelli","sequence":"additional","affiliation":[{"name":"Department of Medicine, Surgery, and Dentistry, Scuola Medica Salernitana, University of Salerno, Baronissi, Italy"},{"name":"Clinical Pharmacology Unit, San Giovanni di Dio e Ruggi d\u2019Aragona University Hospital, Salerno, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2022,4,19]]},"reference":[{"issue":"4","key":"zoi220248r1","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s15010-021-01603-y","article-title":"Characteristics of viral pneumonia in the COVID-19 era: an update.","volume":"49","author":"Pagliano","year":"2021","journal-title":"Infection"},{"key":"zoi220248r2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/JEP.S255209","article-title":"Experimental pharmacotherapy for COVID-19: the latest advances.","volume":"13","author":"Pagliano","year":"2021","journal-title":"J Exp Pharmacol"},{"issue":"2","key":"zoi220248r3","first-page":"198","article-title":"Update on treatment of COVID-19: ongoing studies between promising and disappointing results.","volume":"28","author":"Esposito","year":"2020","journal-title":"Infez Med"},{"issue":"3","key":"zoi220248r4","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/j.xphs.2020.11.019","article-title":"Systems and clinical pharmacology of COVID-19 therapeutic candidates: a clinical and translational medicine perspective.","volume":"110","author":"Perazzolo","year":"2021","journal-title":"J Pharm Sci"},{"issue":"1","key":"zoi220248r5","doi-asserted-by":"publisher","first-page":"12414","DOI":"10.1038\/s41598-021-91953-2","article-title":"Drug-drug interactions between treatment specific pharmacotherapy and concomitant medication in patients with COVID-19 in the first wave in Spain.","volume":"11","author":"Cantudo-Cuenca","year":"2021","journal-title":"Sci Rep"},{"issue":"15","key":"zoi220248r6","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group.","volume":"283","author":"Stroup","year":"2000","journal-title":"JAMA"},{"issue":"7","key":"zoi220248r7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"zoi220248r16","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1016\/j.jad.2020.05.149","article-title":"COVID-19 inpatients with psychiatric disorders: real-world clinical recommendations from an expert team in consultation-liaison psychiatry.","volume":"274","author":"Anmella","year":"2020","journal-title":"J Affect Disord"},{"issue":"4","key":"zoi220248r17","doi-asserted-by":"crossref","DOI":"10.1111\/tid.13286","article-title":"Threatening drug-drug interaction in a kidney transplant patient with coronavirus disease 2019 (COVID-19).","volume":"22","author":"Bartiromo","year":"2020","journal-title":"Transpl Infect Dis"},{"issue":"4","key":"zoi220248r18","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.8857","article-title":"Effect of high vs low doses of chloroquine diphosphate as adjunctive therapy for patients hospitalized with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: a randomized clinical trial.","volume":"3","author":"Borba","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"3","key":"zoi220248r19","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1007\/s11739-020-02586-8","article-title":"Adverse drug reactions in SARS-CoV-2 hospitalised patients: a case-series with a focus on drug-drug interactions.","volume":"16","author":"Crescioli","year":"2021","journal-title":"Intern Emerg Med"},{"issue":"3","key":"zoi220248r20","first-page":"470","article-title":"COVID-19 in a young liver transplant recipient: caution for drug-drug interactions.","volume":"29","author":"Dajti","year":"2020","journal-title":"J Gastrointestin Liver Dis"},{"issue":"1","key":"zoi220248r21","article-title":"Clinical efficacy and safety profile of hydroxychloroquine and azithromycin against COVID-19.","volume":"57","author":"Gautret","year":"2021","journal-title":"Int J Antimicrob Agents"},{"issue":"4","key":"zoi220248r22","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1007\/s13365-020-00869-6","article-title":"Intracranial hemorrhage complicating anticoagulant prophylactic therapy in three hospitalized COVID-19 patients.","volume":"26","author":"Ghani","year":"2020","journal-title":"J Neurovirol"},{"key":"zoi220248r23","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105036","article-title":"Effect of combination antiviral therapy on hematological profiles in 151 adults hospitalized with severe coronavirus disease 2019.","volume":"160","author":"Li","year":"2020","journal-title":"Pharmacol Res"},{"issue":"1","key":"zoi220248r24","doi-asserted-by":"publisher","first-page":"20958","DOI":"10.1038\/s41598-020-78029-3","article-title":"High rate of major drug-drug interactions of lopinavir-ritonavir for COVID-19 treatment.","volume":"10","author":"Mac\u00edas","year":"2020","journal-title":"Sci Rep"},{"issue":"3","key":"zoi220248r25","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1111\/jcpt.v46.3","article-title":"Real-world prevalence and consequences of potential drug-drug interactions in the first-wave COVID-19 treatments.","volume":"46","author":"Mart\u00ednez-L\u00f3pez-de-Castro","year":"2021","journal-title":"J Clin Pharm Ther"},{"issue":"2","key":"zoi220248r26","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1093\/jac\/dkaa441","article-title":"Safety of hydroxychloroquine and darunavir or lopinavir in COVID-19 infection.","volume":"76","author":"Meriglier","year":"2021","journal-title":"J Antimicrob Chemother"},{"issue":"7","key":"zoi220248r27","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1111\/ajt.v20.7","article-title":"Severe COVID-19 in a renal transplant recipient: a focus on pharmacokinetics.","volume":"20","author":"Meziyerh","year":"2020","journal-title":"Am J Transplant"},{"issue":"3","key":"zoi220248r28","doi-asserted-by":"publisher","first-page":"410","DOI":"10.3947\/ic.2020.52.3.410","article-title":"Severe thrombocytopenia in a patient with COVID-19.","volume":"52","author":"Nham","year":"2020","journal-title":"Infect Chemother"},{"issue":"12","key":"zoi220248r29","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.017144","article-title":"Experience with hydroxychloroquine and azithromycin in the coronavirus disease 2019 pandemic: implications for QT interval monitoring.","volume":"9","author":"Ramireddy","year":"2020","journal-title":"J Am Heart Assoc"},{"issue":"9","key":"zoi220248r30","doi-asserted-by":"publisher","first-page":"e438","DOI":"10.1111\/jdv.v34.9","article-title":"A late-onset widespread skin rash in a previous COVID-19-infected patient: viral or multidrug effect?","volume":"34","author":"Skroza","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"zoi220248r31","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1161\/CIRCULATIONAHA.120.047971","article-title":"Spectrum of cardiac manifestations in COVID-19: a systematic echocardiographic study.","volume":"142","author":"Szekely","year":"2020","journal-title":"Circulation"},{"issue":"10","key":"zoi220248r32","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1089\/jpm.2021.0123","article-title":"Acute pain crisis caused by tramadol remdesivir drug-drug interaction.","volume":"24","author":"Teoli","year":"2021","journal-title":"J Palliat Med"},{"issue":"1","key":"zoi220248r33","doi-asserted-by":"crossref","DOI":"10.1111\/tid.13388","article-title":"A case of successful treatment of severe COVID-19 pneumonia with favipiravir and tocilizumab in post-kidney transplant recipient.","volume":"23","author":"Thammathiwat","year":"2021","journal-title":"Transpl Infect Dis"},{"issue":"21","key":"zoi220248r34","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1182\/blood.2020006288","article-title":"The BTK inhibitor ibrutinib may protect against pulmonary injury in COVID-19-infected patients.","volume":"135","author":"Treon","year":"2020","journal-title":"Blood"},{"issue":"5","key":"zoi220248r35","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1177\/1078155220924084","article-title":"Clinical course of COVID-19 infection in elderly patient with melanoma on nivolumab.","volume":"26","author":"Yeked\u00fcz","year":"2020","journal-title":"J Oncol Pharm Pract"},{"issue":"1","key":"zoi220248r36","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1080\/17460441.2021.1970743","article-title":"An overview of the preclinical discovery and development of remdesivir for the treatment of coronavirus disease 2019 (COVID-19).","volume":"17","author":"Pagliano","year":"2022","journal-title":"Expert Opin Drug Discov"},{"issue":"8","key":"zoi220248r37","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in hospitalized patients with COVID-19.","volume":"384","author":"Horby","year":"2021","journal-title":"N Engl J Med"},{"key":"zoi220248r38","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173644","article-title":"Treatment for COVID-19: an overview.","volume":"889","author":"Stasi","year":"2020","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"zoi220248r39","doi-asserted-by":"publisher","first-page":"19765","DOI":"10.1038\/s41598-020-74988-9","article-title":"Clinical presentations, laboratory and radiological findings, and treatments for 11,028 COVID-19 patients: a systematic review and meta-analysis.","volume":"10","author":"Wong","year":"2020","journal-title":"Sci Rep"},{"issue":"7","key":"zoi220248r40","doi-asserted-by":"publisher","first-page":"628","DOI":"10.3390\/jpm11070628","article-title":"Effect of tocilizumab in reducing the mortality rate in COVID-19 patients: a systematic review with meta-analysis.","volume":"11","author":"Conti","year":"2021","journal-title":"J Pers Med"},{"issue":"6","key":"zoi220248r41","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1097\/PRA.0000000000000502","article-title":"Why are patients with COVID-19 at risk for drug-drug interactions?","volume":"26","author":"Preskorn","year":"2020","journal-title":"J Psychiatr Pract"},{"issue":"6","key":"zoi220248r43","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s11897-020-00485-9","article-title":"The complex management of atrial fibrillation and cancer in the COVID-19 era: drug interactions, thromboembolic risk, and proarrhythmia.","volume":"17","author":"Gatti","year":"2020","journal-title":"Curr Heart Fail Rep"},{"issue":"3","key":"zoi220248r44","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.jpainsymman.2010.11.014","article-title":"Adverse drug reactions and drug interactions as causes of hospital admission in oncology.","volume":"42","author":"Miranda","year":"2011","journal-title":"J Pain Symptom Manage"},{"issue":"7","key":"zoi220248r45","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1007\/s00520-014-2160-0","article-title":"Characteristics of unplanned hospital admissions due to drug-related problems in cancer patients.","volume":"22","author":"Chan","year":"2014","journal-title":"Support Care Cancer"},{"issue":"12","key":"zoi220248r47","doi-asserted-by":"publisher","first-page":"2811","DOI":"10.1080\/10428194.2017.1315115","article-title":"Practical recommendations for the choice of anticoagulants in the management of patients with atrial fibrillation on ibrutinib.","volume":"58","author":"Chai","year":"2017","journal-title":"Leuk Lymphoma"},{"issue":"12","key":"zoi220248r48","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3390\/biom10121672","article-title":"Biomarkers to personalize the treatment of rheumatoid arthritis: focus on autoantibodies and pharmacogenetics.","volume":"10","author":"Conti","year":"2020","journal-title":"Biomolecules"},{"issue":"1","key":"zoi220248r49","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.100770","article-title":"Molnupiravir promotes SARS-CoV-2 mutagenesis via the RNA template.","volume":"297","author":"Gordon","year":"2021","journal-title":"J Biol Chem"},{"issue":"5","key":"zoi220248r50","doi-asserted-by":"publisher","first-page":"e02428","DOI":"10.1128\/AAC.02428-20","article-title":"Human safety, tolerability, and pharmacokinetics of molnupiravir, a novel broad-spectrum oral antiviral agent with activity against SARS-CoV-2.","volume":"65","author":"Painter","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"issue":"6575","key":"zoi220248r51","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1126\/science.abl4784","article-title":"An oral SARS-CoV-2 Mpro inhibitor clinical candidate for the treatment of COVID-19.","volume":"374","author":"Owen","year":"2021","journal-title":"Science"},{"key":"zoi220248r8","unstructured":"Drugs.com. Drug Interaction checker. Accessed February 13, 2022. https:\/\/www.drugs.com\/"},{"key":"zoi220248r9","unstructured":"Covid 19 Drug Interaction. Drug Interaction checker. Accessed February 13, 2022. https:\/\/www.covid19-druginteractions.org\/checker"},{"key":"zoi220248r10","unstructured":"Wolters Kluwer. Lexicomp User Academy. Accessed February 13, 2022. https:\/\/www.wolterskluwer.com\/en\/solutions\/lexicomp\/resources\/lexicomp-user-academy\/drug-interactions-analysis"},{"key":"zoi220248r11","unstructured":"Medscape Reference. Drug Interactions Checker. Accessed February 13, 2022. https:\/\/reference.medscape.com\/"},{"key":"zoi220248r12","unstructured":"WebMD. Better information. Better health. Accessed February 13, 2022. https:\/\/www.webmd.com\/"},{"key":"zoi220248r13","unstructured":"European Medicines Agency. Accessed February 13, 2022. https:\/\/www.ema.europa.eu\/en"},{"key":"zoi220248r14","unstructured":"Agenzia Italiana del Farmaco. Accessed February 13, 2022. https:\/\/www.aifa.gov.it\/"},{"key":"zoi220248r15","unstructured":"Clinicaltrials.gov. Accessed February 13, 2022. https:\/\/www.clinicaltrials.gov\/"},{"key":"zoi220248r42","unstructured":"Agenzia Italiana del Farmaco. Uso delle eparine nei pazienti adulti con COVID-19. Accessed February 13, 2022. https:\/\/www.aifa.gov.it\/documents\/20142\/0\/Eparine_Basso_Peso_Molecolare_13.05.2021.pdf"},{"key":"zoi220248r46","unstructured":"CredibleMeds. Accessed February 13, 2022. https:\/\/crediblemeds.org\/"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2791291\/conti_2022_oi_220248_1649859907.04406.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T15:19:02Z","timestamp":1650381542000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2791291"}},"subtitle":["A Systematic Review"],"short-title":[],"issued":{"date-parts":[[2022,4,19]]},"references-count":51,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.7970","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,19]]}}}